AVEO Pharmaceuticals Shares Outstanding 2009-2019 | AVEO

AVEO Pharmaceuticals shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
AVEO Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 131
2017 106
2016 69
2015 56
2014 52
2013 51
2012 43
2011 41
2010 26
2009 2
2008 2
AVEO Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 161
Q2 2019 159
Q1 2019 133
Q4 2018 131
Q3 2018 120
Q2 2018 129
Q1 2018 119
Q4 2017 106
Q3 2017 118
Q2 2017 111
Q1 2017 76
Q4 2016 69
Q3 2016 76
Q2 2016 67
Q1 2016 58
Q4 2015 56
Q3 2015 57
Q2 2015 55
Q1 2015 53
Q4 2014 52
Q3 2014 52
Q2 2014 52
Q1 2014 52
Q4 2013 51
Q3 2013 51
Q2 2013 51
Q1 2013 49
Q4 2012 43
Q3 2012 43
Q2 2012 43
Q1 2012 43
Q4 2011 41
Q3 2011 43
Q2 2011 37
Q1 2011 37
Q4 2010 26
Q3 2010 31
Q2 2010 31
Q1 2010 6
Q4 2009 2
Q3 2009 2
Q2 2009 2
Q1 2009 2
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.085B $0.005B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.503B 15.03
CSL (CSLLY) Australia $103.320B 0.00
Gilead Sciences (GILD) United States $85.208B 10.97
Vertex Pharmaceuticals (VRTX) United States $64.242B 58.30
Biogen (BIIB) United States $59.363B 10.14
Illumina (ILMN) United States $44.570B 46.08
Regeneron Pharmaceuticals (REGN) United States $44.096B 18.68
Alexion Pharmaceuticals (ALXN) United States $22.851B 10.63
Seattle Genetics (SGEN) United States $20.652B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.867B 38.33
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Genmab (GNMSF) Denmark $14.941B 48.06
Galapagos (GLPG) Belgium $14.619B 37.67
Alnylam Pharmaceuticals (ALNY) United States $14.523B 0.00
Exact Sciences (EXAS) United States $13.310B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.577B 0.00
Sarepta Therapeutics (SRPT) United States $9.087B 0.00
QIAGEN (QGEN) Netherlands $8.382B 25.81
Guardant Health (GH) United States $8.138B 0.00
Bio-Techne Corp (TECH) United States $8.079B 55.29
BioNTech SE (BNTX) Germany $7.297B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.061B 0.00
Ascendis Pharma (ASND) Denmark $6.883B 0.00
Reata Pharmaceuticals (RETA) United States $6.782B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
Exelixis (EXEL) United States $6.624B 18.63
Amarin (AMRN) Ireland $6.466B 0.00
Moderna (MRNA) United States $6.367B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.169B 0.00
Repligen (RGEN) United States $5.682B 102.96
Acceleron Pharma (XLRN) United States $5.013B 0.00
China Biologic Products (CBPO) China $4.590B 25.86
Bluebird Bio (BLUE) United States $4.474B 0.00
Adaptive Biotechnologies (ADPT) United States $4.168B 0.00
MorphoSys AG (MOR) Germany $3.939B 0.00
Mirati Therapeutics (MRTX) United States $3.845B 0.00
Zai Lab (ZLAB) China $3.655B 0.00
NeoGenomics (NEO) United States $3.598B 191.47
Ultragenyx Pharmaceutical (RARE) United States $3.563B 0.00
Blueprint Medicines (BPMC) United States $3.561B 0.00
Immunomedics (IMMU) United States $3.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.536B 59.91
Momenta Pharmaceuticals (MNTA) United States $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.334B 33.12
MyoKardia (MYOK) United States $3.176B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.150B 0.00
Genmab (GMAB) Denmark $3.123B 6.43
Halozyme Therapeutics (HALO) United States $3.102B 0.00
Alkermes (ALKS) Ireland $2.946B 233.38
UniQure (QURE) Netherlands $2.830B 0.00
Insmed (INSM) United States $2.773B 0.00
Amicus Therapeutics (FOLD) United States $2.755B 0.00
Arena Pharmaceuticals (ARNA) United States $2.703B 6.29
Denali Therapeutics (DNLI) United States $2.516B 0.00
Principia Biopharma (PRNB) United States $2.313B 0.00
Epizyme (EPZM) United States $2.293B 0.00
Fate Therapeutics (FATE) United States $2.238B 0.00
RA PHARMCTL INC (RARX) United States $2.206B 0.00
Alector (ALEC) United States $2.058B 0.00
REGENXBIO (RGNX) United States $1.988B 0.00
Zymeworks (ZYME) Canada $1.851B 0.00
Ligand Pharmaceuticals (LGND) United States $1.781B 51.99
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.716B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Zealand Pharma (ZEAL) Denmark $1.517B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.503B 0.00
Myriad Genetics (MYGN) United States $1.490B 26.30
Dicerna Pharmaceuticals (DRNA) United States $1.391B 0.00
Editas Medicine (EDIT) United States $1.362B 0.00
Intra-Cellular Therapies (ITCI) United States $1.331B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.207B 0.00
Athenex (ATNX) United States $1.207B 0.00
Revance Therapeutics (RVNC) United States $1.203B 0.00
Adverum Biotechnologies (ADVM) United States $1.046B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Twist Bioscience (TWST) United States $1.008B 0.00
PHARMA MAR SA (PHMMF) Spain $1.005B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.929B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
DBV Technologies S.A (DBVT) France $0.883B 0.00
Sangamo Therapeutics (SGMO) United States $0.866B 0.00
Vericel (VCEL) United States $0.849B 316.67
Codexis (CDXS) United States $0.818B 0.00
Heska (HSKA) United States $0.808B 206.36
Cellectis S.A (CLLS) France $0.789B 0.00
ANI Pharmaceuticals (ANIP) United States $0.759B 12.95
Intrexon (PGEN) United States $0.747B 0.00
Retrophin (RTRX) United States $0.724B 0.00
Arcus Biosciences (RCUS) United States $0.722B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.717B 6.03
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.685B 0.00
GENFIT S.A (GNFT) France $0.681B 0.00
Kadmon Holdings (KDMN) United States $0.667B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.625B 0.00
Anika Therapeutics (ANIK) United States $0.607B 19.71
Agenus (AGEN) United States $0.603B 0.00
NantKwest (NK) United States $0.597B 0.00
Cel-Sci (CVM) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.585B 0.00
AC Immune SA (ACIU) Switzerland $0.578B 13.38
Clovis Oncology (CLVS) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Bellus Health (BLU) Canada $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.543B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.521B 0.00
Compugen (CGEN) Israel $0.502B 0.00
BioDelivery Sciences (BDSI) United States $0.479B 0.00
Prothena (PRTA) Ireland $0.478B 0.00
Cue Biopharma (CUE) United States $0.474B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.455B 0.00
Sorrento Therapeutics (SRNE) United States $0.438B 0.00
Mersana Therapeutics (MRSN) United States $0.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.425B 0.00
AnaptysBio (ANAB) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.418B 0.00
Dynavax Technologies (DVAX) United States $0.417B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.417B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.415B 0.00
PDL BioPharma (PDLI) United States $0.412B 10.31
Avid Bioservices (CDMO) United States $0.405B 0.00
Pfenex (PFNX) United States $0.392B 0.00
Inovio Pharmaceuticals (INO) United States $0.386B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Gritstone Oncology (GRTS) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.363B 0.00
Albireo Pharma (ALBO) United States $0.330B 0.00
CytomX Therapeutics (CTMX) United States $0.329B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.313B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.310B 2.15
Syros Pharmaceuticals (SYRS) United States $0.304B 0.00
OSMOTICA PHARM (OSMT) United States $0.301B 0.00
WAVE Life Sciences (WVE) Singapore $0.297B 0.00
MannKind (MNKD) United States $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.294B 0.00
Aduro Biotech (ADRO) United States $0.290B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.283B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Kamada (KMDA) Israel $0.272B 11.31
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.267B 0.00
Sutro Biopharma (STRO) United States $0.263B 0.00
Geron (GERN) United States $0.260B 0.00
Novavax (NVAX) United States $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.243B 0.00
ChromaDex (CDXC) United States $0.241B 0.00
Protagonist Therapeutics (PTGX) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.230B 0.00
Alcobra (ARCT) United States $0.225B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.225B 11.54
Nymox Pharmaceutical (NYMX) Canada $0.219B 0.00
Theratechnologies (THTX) Canada $0.211B 0.00
Prometic Life Sciences (LMNL) Canada $0.211B 0.00
Cerecor (CERC) United States $0.211B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.207B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.206B 0.00
TELA Bio (TELA) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.203B 0.00
Athersys (ATHX) United States $0.197B 0.00
Fortress Biotech (FBIO) United States $0.194B 0.00
Five Prime Therapeutics (FPRX) United States $0.190B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 5.09
Exicure (XCUR) United States $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.176B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Aptinyx (APTX) United States $0.163B 0.00
Verastem (VSTM) United States $0.158B 0.00
Dyadic (DYAI) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.150B 0.00
Celyad SA (CYAD) Belgium $0.150B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
PHASEBIO PHARMA (PHAS) United States $0.143B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
Menlo Therapeutics (MNLO) United States $0.135B 0.00
Palatin Technologies (PTN) United States $0.134B 3.66
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
ARAVIVE, INC (ARAV) United States $0.134B 0.00
Arsanis (XFOR) United States $0.130B 0.00
OvaScience (MLND) United States $0.124B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Northwest Biotherapeutics (NWBO) United States $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Prima BioMed (IMMP) Australia $0.112B 0.00
Enzo Biochem (ENZ) United States $0.108B 0.00
Happiness Biotech Group (HAPP) China $0.106B 0.00
Applied Genetic Technologies (AGTC) United States $0.101B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.088B 0.00
Proteostasis Therapeutics (PTI) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Emmaus Life Sciences (EMMA) United States $0.083B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.080B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.078B 5.04
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Trevena (TRVN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Advaxis (ADXS) United States $0.064B 0.00
DiaMedica Therapeutics (DMAC) United States $0.064B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.058B 0.00
Bioxytran (BIXT) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
Stellar Biotechnologies (EDSA) Canada $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Celsion (CLSN) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Signal Genetics (MGEN) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00